CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 512 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -80.0% | 512 | -14.7% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 600 | -76.9% | 0.00% | – |
| Q2 2017 | $1,000 | -75.0% | 2,600 | -71.4% | 0.00% | – |
| Q1 2017 | $4,000 | +300.0% | 9,100 | +313.6% | 0.00% | – |
| Q4 2016 | $1,000 | -85.7% | 2,200 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +600.0% | 2,200 | +29.4% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,700 | -63.8% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 4,700 | +6.8% | 0.00% | – |
| Q4 2015 | $4,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |